4.6 Editorial Material

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Journal

INTENSIVE CARE MEDICINE
Volume 46, Issue 4, Pages 586-590

Publisher

SPRINGER
DOI: 10.1007/s00134-020-05985-9

Keywords

-

Funding

  1. Canadian Institutes of Health Research [FDN143285]
  2. National Nature Science Foundation of China [81270125, 81490530, 2018GZR0201002]
  3. Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR0201002]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available